The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.01183-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Martin Okitwi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Research Collaboration, Kampala, Uganda. Hauptthemen laut MEDLINE: Plasmodium falciparum, Artemisinins, Antimalarials, Drug Resistance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, HHS | National Institutes of Health (NIH), Gates Foundation.
Abstract (Originalsprache)
Artemisinin partial resistance (ART-R) has emerged in eastern Africa, necessitating regular surveillance of susceptibility of Plasmodium falciparum to artemisinins. The microscopy-based ring-stage survival assay (RSA) provides a laboratory correlate of ART-R but is limited by low throughput and subjectivity of microscopic counts of viable parasites. The extended recovery ring-stage survival assay (eRRSA) replaces microscopy with efficient quantitative PCR (qPCR) readouts but has been studied only with culture-adapted P. falciparum clones. We measured susceptibility to dihydroartemisinin (DHA) after a 6-h incubation with 700-nM DHA, followed by culture without drug, by comparing survival with that of untreated controls by microscopy (the RSA) or qPCR (the eRRSA) and also performed standard growth inhibition (half-maximal inhibitory concentration [IC 50 ]) assays for 122 P. falciparum isolates freshly collected in eastern and northern Uganda from March to July 2022. The median values for RSA survival, eRRSA fold change, and DHA IC 50 were 3.0%, 46.2, and 3.2 nM, respectively. RSA percent survival and eRRSA fold changes correlated strongly (Spearman correlation coefficient [ r s ] = −0.7411, P < 0.0001), with modest associations between the presence of validated P. falciparum Kelch13 ART-R mutations (C469Y or A675V) and RSA (median survival 2.6% for wild type [WT] vs 4.1% for mutant, P = 0.01), or eRRSA (median fold change 63.4 for WT vs 30.9 for mutant, P = 0.003) results. Significant correlations were also observed between DHA IC 50 values and both RSA percent survival ( r s = 0.4235, P < 0.0001) and eRRSA fold changes ( r s = −0.4116, P < 0.0001). The eRRSA is a scalable alternative for phenotyping fresh P. falciparum isolates, providing similar results with improved throughput.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Research Collaboration, Kampala, Uganda.
- Department of Biological Sciences, Eck Institute for Global Health, University of Notre Dame, Notre Dame, Indiana, USA.
- Dominican University of California, San Rafael, California, USA.
- University of California, San Francisco, California, USA.
- Brown University, Providence, Rhode Island, USA.
ORCID-Profile: Douglas A Shoue, Lisa A Checkley, Oriana K Kreutzfeld, Melissa D Conrad, Philip J Rosenthal, Michael T Ferdig, Roland A Cooper
Förderung
- NIAID NIH HHS
- HHS | National Institutes of Health (NIH)
- Gates Foundation
- Bill and Melinda Gates Foundation
Zitieren
APA
Okitwi, M., Shoue, D. A., Checkley, L. A., Orena, S., Ceja, F. G., Taremwa, Y., Tumwebaze, P. K., Katairo, T., Byaruhanga, O., Sievert, M. A., Garg, S., Kreutzfeld, O. K., Legac, J., Bailey, J. A., Nsobya, S. L., Conrad, M. D., Rosenthal, P. J., Ferdig, M. T., & Cooper, R. A. (2024). The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01183-24
Vancouver
Okitwi M, Shoue DA, Checkley LA, Orena S, Ceja FG, Taremwa Y, et al. The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01183-24
BibTeX
@article{Okitwi2024,
author = {Okitwi, Martin and Shoue, Douglas A and Checkley, Lisa A and Orena, Stephen and Ceja, Frida G and Taremwa, Yoweri and Tumwebaze, Patrick K and Katairo, Thomas and Byaruhanga, Oswald and Sievert, Mackenzie A C and Garg, Shreeya and Kreutzfeld, Oriana K and Legac, Jennifer and Bailey, Jeffrey A and Nsobya, Sam L and Conrad, Melissa D and Rosenthal, Philip J and Ferdig, Michael T and Cooper, Roland A},
title = {The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.01183-24}
}
EUVIMED